Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Forensic Science & Addiction Research

The Emerging MDMA Pandemic

  • Open or Close Suprakash Chaudhury* and Swaleha Mujhawar

    Department of Psychiatry, Dr. D. Y. Patil Medical College, Hospital & Research Centre, India

    *Corresponding author: Suprakash Chaudhury, Department of Psychiatry, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pimpri, Pune- 411018, India

Submission: February 26, 2018; Published: March 20, 2018

DOI: 10.31031/FSAR.2018.03.000552

ISSN: 2578-0042
Volume3 Issue1

Abstract

A new wave of epidemic is emerging that is posing serious mental health risks to people all around the world. This epidemic is caused by a club or party drug 3,4-methylenedioxymethamphetamine (MDMA). MDMA is a psychoactive drug with stimulant and hallucinogenic properties first made in 1912 by the German pharmaceutical company Merck. It was found to improve psychotherapy beginning but later became popular as a street drug in the 1980s [1]. In the year 2017, between 9 and 29 million persons between the ages of 15 and 64 used MDMA i.e. 0.19% to 0.71% of the world population [2]. It is used primarily as a recreational drug associated with the “rave” culture and, as yet, has no accepted medical uses.

Get access to the full text of this article

About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 260 Madison Ave, 8th Floor
  •     New York, NY 10016, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137
  • info@crimsonpublishers.com
  • www.crimsonpublishers.com